Lord, Abbett & Co
MLAB icon

Lord, Abbett & Co’s Mesa Laboratories MLAB Stock Holding History

Lord, Abbett & Co’s Portfolio MLAB Stock Details MLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-23,379
Closed -$2.91M – 870
2017
Q4 		$2.91M Sell
23,379
-6,012
-20% -$841K 0.01% 818
2017
Q3 		$4.39M Buy
+29,391
New +$4.15M 0.01% 785

Other funds holding MLAB

CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
TAM
THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return

Lord, Abbett & Co's MLAB Position: Q1 2018 in Review

Lord, Abbett & Co sold out of Mesa Laboratories (MLAB) in Q1 2018, closing a stake of 23,379 shares — an estimated $2.91M sold.

Lord, Abbett & Co first reported a position in MLAB in Q3 2017 and held it in 2 quarters. The position peaked at $4.39M in Q3 2017. 91 funds tracked by Wall St. Rank hold MLAB as of Q1 2018.

  • Lord, Abbett & Co reported no remaining Mesa Laboratories position as of Q1 2018 after selling out during the quarter.
  • Lord, Abbett & Co sold 23,379 Mesa Laboratories shares in Q1 2018, an estimated $2.91M.
  • Lord, Abbett & Co first reported a position in Mesa Laboratories in Q3 2017 and held it in 2 quarters.
  • Lord, Abbett & Co's Mesa Laboratories position peaked at $4.39M in Q3 2017.
  • 91 funds tracked by Wall St. Rank held Mesa Laboratories as of Q1 2018.

Based on Lord, Abbett & Co's 13F filing for Q1 2018, filed 15 May 2018.